Urinary excretion of parathyroid hormone-related protein fragments in patients with humoral hypercalcemia of malignancy and hypercalcemic tumor-bearing nude mice
Open Access
- 1 January 1991
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 6 (1) , 77-84
- https://doi.org/10.1002/jbmr.5650060113
Abstract
To investigate whether parathyroid hormone-related protein (PTHrP), a hypercalcemia-inducing factor responsible for malignancy-associated hypercalcemia (MAH), is excreted into urine of these patients, radioimmunoassay was established using antiserum specific for the C-terminal region of PTHrP-(127–141). Immunoreactive PTHrP (iPTHrP) was detected in the urine of all patients with MAH (n = 6) in whom nephrogenous cyclic AMP excretion was elevated. However, iPTHrP was not detected in the urine of normal subjects (n = 25) or hypercalcemic patients with primary hyperparathyroidism (n = 8). In normocalcemic patients with malignant disorders iPTHrP was not detected in the urine in most cases (24 of 25 patients) but was detectable in 1 of 25 patients. iPTHrP was also detected in the urine of hypercalcemic nude mice transplanted with PTHrP-producing tumors, but not in the urine of control and normocalcemic nude mice transplanted with PTHrP-nonproducing tumor. Furthermore, size-exclusion high-performance liquid chromatography revealed that the molecular weight of iPTHrP is about 2000–6000 daltons in the urine of patients as well as tumor-bearing nude mice. These data indicate that the fragments of the C-terminal region of PTHrP are excreted into the urine of patients with MAH and in a few normocalcemic patients with malignancies, suggesting that the measurement of iPTHrP in the urine is potentially useful in the differential diagnosis of hypercalcemia, particularly in differentiating humoral hypercalcemia of malignancy and primary hyperparathyroidism.Keywords
Funding Information
- University of Melbourne, Victoria, Australia
- Research Institute of Foundation for Growth Science in Japan
- Grants-in-Aid for Scientific Research
- Kato Memorial Trust for Nambyo Research
- Ministry of Education, Science, and Culture, Japan ((62570521))
- Cancer Research from the Ministry of Health and Welfare, Japan
- Japan Society for Bone and Mineral Research
This publication has 30 references indexed in Scilit:
- Immunochemical Characterization of Circulating Parathyroid Hormone–Related Protein in Patients with Humoral Hypercalcemia of CancerNew England Journal of Medicine, 1990
- Circulating concentrations of parathyroid hormone-like peptide in malignancy and in hyperparathyroidismJournal of Bone and Mineral Research, 1990
- Expression of a Calcium-Mobilizing Parathyroid Hormone-Like Peptide in Lactating Mammary TissueScience, 1988
- Humoral Hypercalcemia of CancerNew England Journal of Medicine, 1988
- Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone.Journal of Clinical Investigation, 1987
- A Parathyroid Hormone-Related Protein Implicated in Malignant Hypercalcemia: Cloning and ExpressionScience, 1987
- Production of bone-resorbing activity and colony-stimulating activity in vivo and in vitro by a human squamous cell carcinoma associated with hypercalcemia and leukocytosis.Journal of Clinical Investigation, 1986
- Prediction of protein antigenic determinants from amino acid sequences.Proceedings of the National Academy of Sciences, 1981
- Renal filtration, transport, and metabolism of low-molecular-weight proteins: A reviewKidney International, 1979
- Drug AddictionBMJ, 1957